Certara Products Archives

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraOctober 15, 2025

Blog

The SDTM Mapping Process Simplified

October 15, 2025 SDTM mapping can be one of the most challenging programming problems in…

CertaraOctober 15, 2025

On-Demand Webinar

Avoiding the MedChem Mutiny

CertaraSeptember 22, 2025

Announcement

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Meet DIDB Concomitant Meds Navigator—an evidence-based tool to identify contraindicated or monitored co-medications and manage…

CertaraSeptember 22, 2025

Announcement

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…

CertaraSeptember 17, 2025

Conference

Redefining Every Stage of Investment (RESI) Seed to Exit

–

CertaraSeptember 5, 2025

On-Demand Webinar

Streamline Table Creation with AI-Specialized for Regulatory Writers

Learn how AI-powered CoAuthor™ transforms table creation for regulatory and medical writers. Watch our free…

CertaraAugust 27, 2025

On-Demand Webinar

Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows

Charles River improved its global pharmacokinetics workflows by adopting Certara’s Integral as a central data…

CertaraAugust 27, 2025

On-Demand Webinar

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Access our on-demand webinar to explore the key differences between eCTD 4.0 and eCTD 3.2.2.…

CertaraAugust 11, 2025

Press Release

Certara Reports Second Quarter 2025 Financial Results

RADNOR, PA— August 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraAugust 6, 2025

Certara Products

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

The SDTM Mapping Process Simplified

Avoiding the MedChem Mutiny

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC

Redefining Every Stage of Investment (RESI) Seed to Exit

Streamline Table Creation with AI-Specialized for Regulatory Writers

Certara Integral: The Master Data Repository Powering Efficient and Collaborative PK/PD Workflows

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Certara Reports Second Quarter 2025 Financial Results

Newsletter sign up

Quick links

Solutions

Contact